Assessing the Continuation of Glucagon-Like Peptide-1 Receptor Agonists When Weight and HBA1C Are Not Reduced-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessing the Continuation of Glucagon-Like Peptide-1 Receptor Agonists When Weight and HBA1C Are Not Reduced

Published:2020-09-01 Issue:7 Volume:18 Page:321-327
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Zhou Rona¹,Duncan Karsten¹,Lopez Julio¹,Rich Kjersti¹,Swislocki Arthur²³

Affiliation:

1. Pharmacy Service, Veterans Affairs Northern California Health Care System (VANCHCS), Sacramento, California, USA.

2. Medical Service, Veterans Affairs Northern California Health Care System (VANCHCS), Sacramento, California, USA.

3. Department of Internal Medicine, UC Davis School of Medicine, Sacramento, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/met.2019.0122

Reference30 articles.

1. GLP-1 receptor agonists: a review of head-to-head clinical studies

2. American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015

3. Association Between Glycosylated Hemoglobin and Intentional Weight Loss in Overweight and Obese Patients With Type 2 Diabetes Mellitus

4. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP